Citation Impact
Citing Papers
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
2009 StandoutScience
Directing polymorph specific calcium carbonate formation with de novo protein templates
2023 StandoutNobel
The complexities of skeletal biology
2003 StandoutNature
Chemokines and allergic disease
1999
Regulation of the differentiation and function of osteoclasts
2000
Triggering Cell Death
1999
Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo
1999 Standout
Expression of osteopontin messenger RNA and protein in rheumatoid arthritis: Effects of osteopontin on the release of collagenase 1 from articular chondrocytes and synovial fibroblasts
2000
Osteopontin expression and function: Role in bone remodeling
1998
Localization of RANKL (receptor activator of NFκB ligand) mRNA and protein in skeletal and extraskeletal tissues
1999
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
1999 Standout
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) Apoptosis Systems
2000
Role of RANK ligand in mediating increased bone resorption in early postmenopausal women
2003
Reaching a Genetic and Molecular Understanding of Skeletal Development
2002 Standout
Proliferation, cell cycle and apoptosis in cancer
2001 StandoutNature
Insights into the activation mechanism of class I HDAC complexes by inositol phosphates
2016
The Hallmarks of Cancer
2000 Standout
High levels of osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in serum of rheumatoid arthritis patients and their normalization after anti–tumor necrosis factor α treatment
2002
Cell Death
2004 Standout
The Epigenomics of Cancer
2007 Standout
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
Osteoporosis: now and the future
2011 Standout
Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
2012 Standout
Prospects: Histone deacetylase inhibitors
2005
The biochemistry of apoptosis
2000 StandoutNature
Safety and antitumor activity of recombinant soluble Apo2 ligand
1999 Standout
Epigenetics in Cancer
2008 Standout
Anticancer activities of histone deacetylase inhibitors
2006 Standout
RANK is essential for osteoclast and lymph node development
1999
Receptor activator of NF-?B ligand, macrophage inflammatory protein-1?, and the proteasome
2003
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
Regulation of osteoclast activity
1999
Regulation of Osteoclast Formation and Function*
2001
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
2007 StandoutNature
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
2021 StandoutNobel
Targeting apoptosis in cancer therapy
2020 Standout
Asthma
2001 Standout
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
2010 Standout
T cell life and death signalling via TNF-receptor family members
2000
Apoptosis
2002 Standout
Osteoclast differentiation and activation
2003 StandoutNature
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
2004 StandoutNature
Therapeutic application of histone deacetylase inhibitors for central nervous system disorders
2008
Histone deacetylase inhibitors: molecular mechanisms of action
2007
Apoptosis control by death and decoy receptors
1999
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Induction of TNF Receptor I-Mediated Apoptosis via Two Sequential Signaling Complexes
2003 Standout
Osteoprotegerin Ligand Modulates Murine Osteoclast Survival in Vitro and in Vivo
2000
Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells
2009
Mechanisms of Bone Metastasis
2004 Standout
Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival
2001 Standout
The TNF and TNF Receptor Superfamilies
2001 Standout
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
2013 StandoutNature
Controlling protein assembly on inorganic crystals through designed protein interfaces
2019 StandoutNatureNobel
Differential regulation of osteoblasts by substrate microstructural features
2004
Targeting death and decoy receptors of the tumour-necrosis factor superfamily
2002
The TRAF Family of Signal Transducers Mediates NF-κB Activation by the TRANCE Receptor
1998 StandoutNobel
Leptin Inhibits Bone Formation through a Hypothalamic Relay
2000 Standout
Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer
1998 Nature
TRANCE is a TNF family member that regulates dendritic cell and osteoclast function
1999
To die or not to die—the quest of the TRAIL receptors
1999
The Bcl-2 Protein Family: Arbiters of Cell Survival
1998 StandoutScience
Osteopontin Facilitates Angiogenesis, Accumulation of Osteoclasts, and Resorption in Ectopic Bone*
2001
Cell Activation and Apoptosis by Bacterial Lipoproteins Through Toll-like Receptor-2
1999 StandoutScience
The Roles of Osteoprotegerin and Osteoprotegerin Ligand in the Paracrine Regulation of Bone Resorption
2000
Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells.
2000
RANK Ligand and Osteoprotegerin
2002
A Single-Dose Placebo-Controlled Study of AMG 162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal Women
2004
Bone Resorption by Osteoclasts
2000 StandoutScience
Trance, a Tumor Necrosis Factor Family Member, Enhances the Longevity and Adjuvant Properties of Dendritic Cells in Vivo
2000 StandoutNobel
RANK-L and RANK: T Cells, Bone Loss, and Mammalian Evolution
2002
Death Receptors: Signaling and Modulation
1998 StandoutScience
Polymorphisms in the Osteoprotegerin Gene Are Associated With Osteoporotic Fractures
2002
Exploring and Engineering the Cell Surface Interface
2005 StandoutScience
Parathyroid Hormone Stimulates TRANCE and Inhibits Osteoprotegerin Messenger Ribonucleic Acid Expression in Murine Bone Marrow Cultures: Correlation with Osteoclast-Like Cell Formation*
1999
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
Regulation of apoptosis by the circadian clock through NF-κB signaling
2011 StandoutNobel
Fas Preassociation Required for Apoptosis Signaling and Dominant Inhibition by Pathogenic Mutations
2000 StandoutScienceNobel
Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
Involvement of TRAIL and its receptors in viral hepatitis
2002
HDACs and HDAC Inhibitors in Cancer Development and Therapy
2016
Osteopontin Expression by Osteoclast and Osteoblast Progenitors in the Murine Bone Marrow: Demonstration of Its Requirement for Osteoclastogenesis and Its Increase After Ovariectomy*
1997
Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families
1999 Standout
Osteopontin
2000 Standout
Cell Survival Promoted by the Ras-MAPK Signaling Pathway by Transcription-Dependent and -Independent Mechanisms
1999 StandoutScience
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Role of RANK ligand in mediating increased bone resorption in early postmenopausal women
2003
Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis
1996 StandoutNobel
Caspases: Enemies Within
1998 StandoutScience
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
2011 Standout
CLINICAL DEVELOPMENT OF HISTONE DEACETYLASE INHIBITORS AS ANTICANCER AGENTS
2004
Works of Edward Dul being referenced
Identification of Novel Isoform-Selective Inhibitors within Class I Histone Deacetylases
2003
Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAIL
1998
Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils
1997
Potent, Selective and Orally Bioavailable Dihydropyrimidine Inhibitors of Rho Kinase (ROCK1) as Potential Therapeutic Agents for Cardiovascular Diseases
2008
Human osteoclasts, not osteoblasts, deposit osteopontin onto resorption surfaces: An in vitro and ex vivo study of remodeling bone
1995